BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17056200)

  • 1. Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors.
    Suzuki M; Sakurai Y; Nagata K; Kinashi Y; Masunaga S; Ono K; Maruhashi A; Kato I; Fuwa N; Hiratsuka J; Imahori Y
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1523-7. PubMed ID: 17056200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
    Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
    Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Välimäki P; Mäkitie A; Seppänen M; Minn H; Revitzer H; Kouri M; Kotiluoto P; Seren T; Auterinen I; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e67-75. PubMed ID: 21300462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results of boron neutron capture therapy using intra-arterial administration of boron compounds for recurrent head and neck cancer.
    Fuwa N; Suzuki M; Sakurai Y; Nagata K; Kinashi Y; Masunaga S; Maruhashi A; Imahori Y; Kodaira T; Tachibana H; Nakamura T; Ono K
    Br J Radiol; 2008 Sep; 81(969):749-52. PubMed ID: 18541628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma.
    Suzuki M; Tanaka H; Sakurai Y; Kashino G; Yong L; Masunaga S; Kinashi Y; Mitsumoto T; Yajima S; Tsutsui H; Sato T; Maruhashi A; Ono K
    Radiother Oncol; 2009 Jul; 92(1):89-95. PubMed ID: 19329206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated Boron Neutron Capture Therapy in Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial.
    Wang LW; Chen YW; Ho CY; Hsueh Liu YW; Chou FI; Liu YH; Liu HM; Peir JJ; Jiang SH; Chang CW; Liu CS; Lin KH; Wang SJ; Chu PY; Lo WL; Kao SY; Yen SH
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):396-403. PubMed ID: 27084657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.
    Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1584-9. PubMed ID: 17056195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
    Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
    Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine.
    Coderre JA; Joel DD; Micca PL; Nawrocky MM; Slatkin DN
    Radiat Res; 1992 Mar; 129(3):290-6. PubMed ID: 1542717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose of gamma irradiation enhanced boronophenylalanine uptake in head and neck carcinoma cells for boron neutron capture therapy.
    Lin YC; Wang SJ; Chung HP; Liu HM; Chou FI
    Appl Radiat Isot; 2011 Dec; 69(12):1728-31. PubMed ID: 21393007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
    H-Stenstam B
    Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
    [No Abstract]   [Full Text] [Related]  

  • 15. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
    Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report.
    Haginomori S; Miyatake S; Inui T; Araki M; Kawabata S; Takamaki A; Lee K; Takenaka H; Kuroiwa T; Uesugi Y; Kumada H; Ono K
    Head Neck; 2009 Mar; 31(3):412-8. PubMed ID: 18767175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BNCT treatment planning of recurrent head-and-neck cancer using THORplan.
    Yu HT; Liu YW; Lin TY; Wang LW
    Appl Radiat Isot; 2011 Dec; 69(12):1907-10. PubMed ID: 21458281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric evaluation of neutron capture therapy for local advanced breast cancer.
    Yanagie H; Kumada H; Sakurai Y; Nakamura T; Furuya Y; Sugiyama H; Ono K; Takamoto S; Eriguchi M; Takahashi H
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S63-6. PubMed ID: 19427224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron Neutron Capture Therapy in the Treatment of Recurrent Laryngeal Cancer.
    Haapaniemi A; Kankaanranta L; Saat R; Koivunoro H; Saarilahti K; Mäkitie A; Atula T; Joensuu H
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):404-410. PubMed ID: 26797537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.